Home

キャンベラ 慎重に カート 2 pro psa 翻訳 マトン バルク

A Review on the Clinical Utility of PSA in Cancer Prostate. - Abstract -  Europe PMC
A Review on the Clinical Utility of PSA in Cancer Prostate. - Abstract - Europe PMC

Multivariate analysis of À 2[pro]PSA and PSA predicting organ-confined... |  Download Table
Multivariate analysis of À 2[pro]PSA and PSA predicting organ-confined... | Download Table

Immunohistochemical Staining of Precursor Forms of Prostate-specific  Antigen (proPSA) in Metastatic Prostate Cancer Anil V. Parwani, MD, PhD,*  Cameron. - ppt download
Immunohistochemical Staining of Precursor Forms of Prostate-specific Antigen (proPSA) in Metastatic Prostate Cancer Anil V. Parwani, MD, PhD,* Cameron. - ppt download

ProPSA, un nuevo biomarcador para la detección y el manejo del cáncer de  próstata | Revista del Laboratorio Clínico
ProPSA, un nuevo biomarcador para la detección y el manejo del cáncer de próstata | Revista del Laboratorio Clínico

Clinical performance of serum isoform 2pro PSA p
Clinical performance of serum isoform 2pro PSA p

PSA Isoforms in Prostate Cancer Detection - European Urology Supplements
PSA Isoforms in Prostate Cancer Detection - European Urology Supplements

The Next Generation of Prostate Cancer Detection: How to Make PSA a Better  Marker Linda C. Rogers, PhD, DABCC, FACB Scientific Affairs Beckman  Coulter, - ppt download
The Next Generation of Prostate Cancer Detection: How to Make PSA a Better Marker Linda C. Rogers, PhD, DABCC, FACB Scientific Affairs Beckman Coulter, - ppt download

Prostate-specific antigen (PSA) isoform p2PSA significantly improves the  prediction of prostate cancer at initial extended prostate biopsies in  patients with total PSA between 2.0 and 10 ng/ml: results of a prospective  study
Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study

PDF) ProPSA is an early marker for prostate cancer aggressiveness
PDF) ProPSA is an early marker for prostate cancer aggressiveness

Evaluation of [−2] proPSA and Prostate Health Index (phi) for the detection  of prostate cancer: a systematic review and meta-analysis
Evaluation of [−2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis

Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical  and Clinical Aspects | SpringerLink
Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical Aspects | SpringerLink

Relationship of Chronic Histologic Prostatic Inflammation in Biopsy  Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate  Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL  and Normal Digital
Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital

Human p2PSA ELISA Kit (A8177) | Antibodies.com
Human p2PSA ELISA Kit (A8177) | Antibodies.com

Diederick Duijvesz CPv3.split.indd
Diederick Duijvesz CPv3.split.indd

PSA synthesis and PSA isoforms. PSA synthesis begins with the cleavage... |  Download Scientific Diagram
PSA synthesis and PSA isoforms. PSA synthesis begins with the cleavage... | Download Scientific Diagram

PSA Screening: Pro
PSA Screening: Pro

The performance of [-2]proPSA and prostate health index tumor markers in  prostate cancer diagnosis | Semantic Scholar
The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis | Semantic Scholar

Human p2PSA ELISA Kit | Abbexa Ltd
Human p2PSA ELISA Kit | Abbexa Ltd

Clinical performance of serum isoform [-2]proPSA (p2PSA) and its  derivatives, namely %p2PSA and PHI (Prostate Health Index) in men younger  than 60 years. - ppt scaricare
Clinical performance of serum isoform [-2]proPSA (p2PSA) and its derivatives, namely %p2PSA and PHI (Prostate Health Index) in men younger than 60 years. - ppt scaricare

Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA)  to Exosomal Biomarkers. - Abstract - Europe PMC
Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers. - Abstract - Europe PMC

PSA biosynthesis. Prostate Specific Antigen (PSA) pre-pro precursor... |  Download Scientific Diagram
PSA biosynthesis. Prostate Specific Antigen (PSA) pre-pro precursor... | Download Scientific Diagram

Molecular forms of PSA. Notes: In serum, PSA (80%-95%) circulates... |  Download Scientific Diagram
Molecular forms of PSA. Notes: In serum, PSA (80%-95%) circulates... | Download Scientific Diagram

The performance of [-2]proPSA and prostate health index tumor markers in  prostate cancer diagnosis
The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis

Preanalytical stability of [-2]proPSA in whole blood stored at room  temperature before separation of serum and plasma: implications to Phi  determination
Preanalytical stability of [-2]proPSA in whole blood stored at room temperature before separation of serum and plasma: implications to Phi determination

Figure 2 from Next-generation prostate-specific antigen test: precursor  form of prostate-specific antigen | Semantic Scholar
Figure 2 from Next-generation prostate-specific antigen test: precursor form of prostate-specific antigen | Semantic Scholar

Aberrant PSA glycosylation—a sweet predictor of prostate cancer | Nature  Reviews Urology
Aberrant PSA glycosylation—a sweet predictor of prostate cancer | Nature Reviews Urology

Table 1 from Serum index test %[-2]proPSA and Prostate Health Index are  more accurate than prostate specific antigen and %fPSA in predicting a  positive repeat prostate biopsy. | Semantic Scholar
Table 1 from Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy. | Semantic Scholar

Emerging biomarkers in the detection and prognosis of prostate cancer in:  Clinical Chemistry and Laboratory Medicine (CCLM) Volume 53 Issue 7 (2015)
Emerging biomarkers in the detection and prognosis of prostate cancer in: Clinical Chemistry and Laboratory Medicine (CCLM) Volume 53 Issue 7 (2015)

2]proPSA is an early marker for prostate cancer aggressiveness | Prostate  Cancer and Prostatic Diseases
2]proPSA is an early marker for prostate cancer aggressiveness | Prostate Cancer and Prostatic Diseases